M Maral Mouradian

Title: M Maral Mouradian: Innovator in Neurodegenerative Disease Treatments

Introduction

M Maral Mouradian is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of neurodegenerative diseases, particularly in the treatment of dyskinesia and alpha-synucleinopathies. With a total of 4 patents to her name, her work is paving the way for innovative therapies that address complex neurological conditions.

Latest Patents

Mouradian's latest patents include a method of treating dyskinesia, which involves administering a therapeutically effective amount of a dual-action μ-opioid receptor antagonist/κ-opioid receptor agonist or a prodrug thereof. This method aims to mitigate dyskinesia in patients. Additionally, she has developed therapies and assays for RNA targeting in alpha-synucleinopathies, focusing on small molecules that can be therapeutically useful in controlling neurodegenerative diseases such as Parkinson's disease.

Career Highlights

Mouradian is affiliated with Rutgers, the State University of New Jersey, where she continues her research and development efforts. Her work has garnered attention for its potential to transform treatment approaches for patients suffering from debilitating neurological disorders.

Collaborations

Some of her notable coworkers include Steven P Braithwaite and Michael Voronkov, who contribute to her research initiatives and collaborative projects.

Conclusion

M Maral Mouradian's innovative work in the field of neurodegenerative diseases highlights her commitment to advancing medical science. Her patents and research efforts are instrumental in developing new therapies that could significantly improve the quality of life for patients.